TAK733, TAK-733, TAK 733, MEK1, MEK, MAP2K, MAPKK, Inhibitor, inhibit, Mitogen-activated protein kinase kinase
TAK-733 is a selective, orally active MEK1/2 inhibitor used in cancer research. It has demonstrated antitumor activity in preclinical studies, inhibiting tumor growth in various in vivo models and cell proliferation in vitro, particularly within the MAPK/ERK pathway.